Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-10-017668)

Filing Details

Accession Number:: 0001104659-10-017668
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-31 13:00:00
Reporting Period:: 2010-03-29

Filing Date:: 2010-03-31
Accepted Time:: 2010-03-31 15:05:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1346450	P L Vii Fund Venture Atlas	C/O Atlas Ventur 890 Winter Street, Suite 320 Waltham MA 02451		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-29	140,000	$7.56	1,337,612	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents 1,262,163 shares of Common Stock and 75,449 warrants to purchase shares of Common Stock held by Atlas Venture Fund VII, L.P. These shares are held directly by AV VII. Atlas Venture Associates VII, L.P., or AVA VII LP, is the sole general partner of AV VII. Each of Atlas VII and AVA VII LP disclaims beneficial ownership of such shares except to the extent of it's pecuniary interest therein.